Literature DB >> 30936073

Exosomal miRNA Cargo as Mediator of Immune Escape Mechanisms in Neuroblastoma.

Thomas D Schmittgen1,2.   

Abstract

Both natural killer (NK) cells and exosomes released from these cells induce tumor cell cytotoxicity by way of the cell killing proteins perforin and granzyme. TGFβ1 protein in the tumor microenvironment generates an immune escape mechanism rendering NK cells inactive. The tumor-suppressive miR-186 that is downregulated in neuroblastoma and in TGFβ-treated NK cells represses oncogenic proteins in neuroblastoma (MYCN and AURKA) and components of the TGFβ pathway. Restoration of miR-186 levels in neuroblastoma through NK cell-derived exosomes or by nanoparticle delivery reduces tumor burden, promotes survival, and restores the cell-killing abilities of NK cells, demonstrating the therapeutic potential of tumor-suppressive miRNAs in neuroblastoma.See related article by Neviani and colleagues; Cancer Res 79(6):1151-64. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30936073      PMCID: PMC7279940          DOI: 10.1158/0008-5472.CAN-19-0021

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  miR-186 inhibits proliferation, migration, and epithelial-mesenchymal transition in breast cancer cells by targeting Twist1.

Authors:  Wen-Juan Sun; Ya-Na Zhang; Peng Xue
Journal:  J Cell Biochem       Date:  2018-12-14       Impact factor: 4.429

2.  Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.

Authors:  Paolo Neviani; Petra M Wise; Mariam Murtadha; Cathy W Liu; Chun-Hua Wu; Ambrose Y Jong; Robert C Seeger; Muller Fabbri
Journal:  Cancer Res       Date:  2018-12-12       Impact factor: 12.701

3.  Immune surveillance properties of human NK cell-derived exosomes.

Authors:  Luana Lugini; Serena Cecchetti; Veronica Huber; Francesca Luciani; Gianfranco Macchia; Francesca Spadaro; Luisa Paris; Laura Abalsamo; Marisa Colone; Agnese Molinari; Franca Podo; Licia Rivoltini; Carlo Ramoni; Stefano Fais
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

4.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

Authors:  R C Seeger; G M Brodeur; H Sather; A Dalton; S E Siegel; K Y Wong; D Hammond
Journal:  N Engl J Med       Date:  1985-10-31       Impact factor: 91.245

5.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

Authors:  Yongxin Chen; Raymond L Stallings
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

6.  Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma.

Authors:  Tobias Otto; Sebastian Horn; Markus Brockmann; Ursula Eilers; Lars Schüttrumpf; Nikita Popov; Anna Marie Kenney; Johannes H Schulte; Roderick Beijersbergen; Holger Christiansen; Bernd Berwanger; Martin Eilers
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

7.  Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cells.

Authors:  Roberta Castriconi; Alessandra Dondero; Francesca Bellora; Lorenzo Moretta; Aurora Castellano; Franco Locatelli; Maria Valeria Corrias; Alessandro Moretta; Cristina Bottino
Journal:  J Immunol       Date:  2013-04-10       Impact factor: 5.422

8.  Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells.

Authors:  Ambrose Y Jong; Chun-Hua Wu; Jingbo Li; Jianping Sun; Muller Fabbri; Alan S Wayne; Robert C Seeger
Journal:  J Extracell Vesicles       Date:  2017-02-28

Review 9.  The MYCN Protein in Health and Disease.

Authors:  María Victoria Ruiz-Pérez; Aine Brigette Henley; Marie Arsenian-Henriksson
Journal:  Genes (Basel)       Date:  2017-03-30       Impact factor: 4.096

Review 10.  Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma.

Authors:  Thitinee Vanichapol; Somchai Chutipongtanate; Usanarat Anurathapan; Suradej Hongeng
Journal:  Biomed Res Int       Date:  2018-02-25       Impact factor: 3.411

  10 in total
  17 in total

Review 1.  Exosomal non-coding RNAs: Emerging roles in bilateral communication between cancer cells and macrophages.

Authors:  Wenhao Li; Xiaolong Wang; Chen Li; Tong Chen; Qifeng Yang
Journal:  Mol Ther       Date:  2021-12-02       Impact factor: 11.454

Review 2.  Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?

Authors:  Muller Fabbri
Journal:  Cancer Res       Date:  2019-10-31       Impact factor: 12.701

3.  Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.

Authors:  Bo Chen; Zhongyan Hua; Xiuni Qin; Zhijie Li
Journal:  Neurochem Res       Date:  2020-10-26       Impact factor: 3.996

4.  miRNA-34a-5p regulates progression of neuroblastoma via modulating the Wnt/β-catenin signaling pathway by targeting SOX4.

Authors:  Yue Wang; Enqing Guan; Dehua Li; Lirong Sun
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 5.  Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

Authors:  Daniel W Binzel; Xin Li; Nicolas Burns; Eshan Khan; Wen-Jui Lee; Li-Ching Chen; Satheesh Ellipilli; Wayne Miles; Yuan Soon Ho; Peixuan Guo
Journal:  Chem Rev       Date:  2021-05-26       Impact factor: 72.087

6.  Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.

Authors:  Shuchun Wei; Lei Peng; Jiajia Yang; Huaiming Sang; Duochen Jin; Xuan Li; Meihong Chen; Weifeng Zhang; Yini Dang; Guoxin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-02-10

Review 7.  Molecular targeting therapies for neuroblastoma: Progress and challenges.

Authors:  Atif Zafar; Wei Wang; Gang Liu; Xinjie Wang; Wa Xian; Frank McKeon; Jennifer Foster; Jia Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2020-11-06       Impact factor: 12.944

Review 8.  miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment.

Authors:  Ilaria Conti; Gabriele Varano; Carolina Simioni; Ilaria Laface; Daniela Milani; Erika Rimondi; Luca M Neri
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

Review 9.  Exosomal miRNAs in tumor microenvironment.

Authors:  Shiming Tan; Longzheng Xia; Pin Yi; Yaqian Han; Lu Tang; Qing Pan; Yutong Tian; Shan Rao; Linda Oyang; Jiaxin Liang; Jinguan Lin; Min Su; Yingrui Shi; Deliang Cao; Yujuan Zhou; Qianjin Liao
Journal:  J Exp Clin Cancer Res       Date:  2020-04-16

Review 10.  Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors.

Authors:  Pierre Autin; Christophe Blanquart; Delphine Fradin
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.